Gvozdjáková A, Sumbalová Z, Kucharská J, Komlósi M, Rausová Z, Vančová O, Számošová M, Mojto V (2020) Platelet mitochondrial respiration, endogenous coenzyme q(10) and oxidative stress in patients with chronic kidney disease. Diagnostics (Basel, Switzerland). https://doi.org/10.3390/diagnostics10030176

Article  PubMed  Google Scholar 

Shouman MG, Sabry S, Galal REE, Salama E, Wahby AA, Awadallah E, Selim A (2019) Oxidative stress in hemodialysis pediatric patients. Open Access Maced J Med Sci 7(23):3955–3959. https://doi.org/10.3889/oamjms.2019.859

Article  PubMed  PubMed Central  Google Scholar 

Signorini L, Granata S, Lupo A, Zaza G (2017) Naturally occurring compounds: New potential weapons against oxidative stress in chronic kidney disease. Int J Mol Sci. https://doi.org/10.3390/ijms18071481

Article  PubMed  PubMed Central  Google Scholar 

Ghobrial EE, Mahfouz NN, Fathy GA, Elwakkad AA, Sebaii HM (2013) Oxidative stress in Egyptian hemodialysis children. Iran J Kidney Dis 7(6):485–491

PubMed  Google Scholar 

Fan L, Feng Y, Chen GC, Qin LQ, Fu CL, Chen LH (2017) Effects of coenzyme Q10 supplementation on inflammatory markers: a systematic review and meta-analysis of randomized controlled trials. Pharmacol Res 119:128–136. https://doi.org/10.1016/j.phrs.2017.01.032

Article  PubMed  CAS  Google Scholar 

Garrido-Maraver J, Cordero MD, Oropesa-Avila M, Vega AF, Mata MDL, Pavon AD, Alcocer-Gomez E, Calero CP, Paz MV, Alanis M, Lavera ID, Cotan D, Alcázar JAS (2014) Clinical applications of coenzyme Q10. Front Biosci 19(4):619–633. https://doi.org/10.2741/4231

Article  CAS  Google Scholar 

Rivara MB, Yeung CK, Robinson-Cohen C, Phillips BR, Ruzinski J, Rock D, Linke L, Shen DD, Ikizler TA, Himmelfarb J (2017) Effect of coenzyme Q(10) on biomarkers of oxidative stress and cardiac function in hemodialysis patients: the CoQ(10) biomarker trial. Am J Kidney Dis 69(3):389–399. https://doi.org/10.1053/j.ajkd.2016.08.041

Article  PubMed  CAS  Google Scholar 

Sakata T, Furuya R, Shimazu T, Odamaki M, Ohkawa S, Kumagai H (2008) Coenzyme Q10 administration suppresses both oxidative and antioxidative markers in hemodialysis patients. Blood Purif 26(4):371–378. https://doi.org/10.1159/000135605

Article  PubMed  CAS  Google Scholar 

Singh RB, Kumar A, Niaz MA, Singh RG, Gujrati S, Singh VP, Singh M, Singh UP, Taneja C, Rastogi SS (2003) Randomized, double-blind, placebo-controlled trial of coenzyme Q10 in patients with end-stage renal failure. J Nutr Environ Med 13(1):13–22. https://doi.org/10.1080/1359084031000095002

Article  CAS  Google Scholar 

Yeung CK, Billings FTT, Claessens AJ, Roshanravan B, Linke L, Sundell MB, Ahmad S, Shao B, Shen DD, Ikizler TA, Himmelfarb J (2015) Coenzyme q10 dose-escalation study in hemodialysis patients: safety, tolerability, and effect on oxidative stress. BMC Nephrol 16:183. https://doi.org/10.1186/s12882-015-0178-2

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zahed NS, Ghassami M, Nikbakht H (2016) Effects of coenzyme q10 supplementation on c-reactive protein and homocysteine as the inflammatory markers in hemodialysis patients; a randomized clinical trial. J Nephropathol 5(1):38–43. https://doi.org/10.15171/jnp.2016.07

Article  PubMed  Google Scholar 

Butler MG, Dasouki M, Bittel D, Hunter S, Naini A, DiMauro S (2003) Coenzyme Q10 levels in Prader–Willi syndrome: comparison with obese and non-obese subjects. Am J Med Genet Part A 119(2):168–171. https://doi.org/10.1002/ajmg.a.10055

Article  Google Scholar 

Elshershari H, Ozer S, Ozkutlu S, Ozme S (2003) Potential usefulness of coenzyme q10 in the treatment of idiopathic dilated cardiomyopathy in children. Int J Cardiol 88(1):101–102. https://doi.org/10.1016/s0167-5273(02)00385-6

Article  PubMed  Google Scholar 

Gamal F, El Agami O, Salamah A (2022) Coenzyme Q10 in the treatment of attention deficit hyperactivity disorder in children: a randomized controlled trial. CNS Neurol Disord Drug Targets 21(8):717–723. https://doi.org/10.2174/1871527320666211124093345

Article  PubMed  CAS  Google Scholar 

Miles MV, Patterson BJ, Schapiro MB, Hickey FJ, Chalfonte-Evans M, Horn PS, Hotze SL (2006) Coenzyme Q10 absorption and tolerance in children with down syndrome: a dose-ranging trial. Pediatr Neurol 35(1):30–37. https://doi.org/10.1016/j.pediatrneurol.2005.11.004

Article  PubMed  Google Scholar 

Mousavinejad E, Ghaffari MA, Riahi F, Hajmohammadi M, Tiznobeyk Z, Mousavinejad M (2018) Coenzyme q(10) supplementation reduces oxidative stress and decreases antioxidant enzyme activity in children with autism spectrum disorders. Psychiatry Res 265:62–69. https://doi.org/10.1016/j.psychres.2018.03.061

Article  PubMed  CAS  Google Scholar 

Slater SK, Nelson TD, Kabbouche MA, LeCates SL, Horn P, Segers A, Manning P, Powers SW, Hershey AD (2011) A randomized, double-blinded, placebo-controlled, crossover, add-on study of coenzyme q10 in the prevention of pediatric and adolescent migraine. Cephalalgia Int J Headache 31(8):897–905. https://doi.org/10.1177/0333102411406755

Article  Google Scholar 

Schulz KF, Altman DG, Moher D (2010) Consort 2010 statement: updated guidelines for reporting parallel group randomised trials. Trials 11:32. https://doi.org/10.1186/1745-6215-11-32

Article  PubMed  PubMed Central  Google Scholar 

Di Giovanni S, Mirabella M, Spinazzola A, Crociani P, Silvestri G, Broccolini A, Tonali P, Di Mauro S, Servidei S (2001) Coenzyme q10 reverses pathological phenotype and reduces apoptosis in familial coq10 deficiency. Neurology 57(3):515–518. https://doi.org/10.1212/wnl.57.3.515

Article  PubMed  Google Scholar 

Hanisch F, Zierz S (2003) Only transient increase of serum coq subset 10 during long-term CoQ10 therapy in mitochondrial ophthalmoplegia. Eur J Med Res 8(11):485–491

PubMed  CAS  Google Scholar 

Marriage BJ, Clandinin MT, Macdonald IM, Glerum DM (2004) Cofactor treatment improves ATP synthetic capacity in patients with oxidative phosphorylation disorders. Mol Genet Metab 81(4):263–272. https://doi.org/10.1016/j.ymgme.2003.12.008

Article  PubMed  CAS  Google Scholar 

Rötig A, Appelkvist EL, Geromel V, Chretien D, Kadhom N, Edery P, Lebideau M, Dallner G, Munnich A, Ernster L, Rustin P (2000) Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme q10 deficiency. Lancet (London, England) 356(9227):391–395. https://doi.org/10.1016/s0140-6736(00)02531-9

Article  PubMed  Google Scholar 

Scarlato G, Bresolin N, Moroni I, Doriguzzi C, Castelli E, Comi G, Angelini C, Carenzi A (1991) Multicenter trial with ubidecarenone: treatment of 44 patients with mitochondrial myopathies. Revue Neurologique 147(6–7):542–548

PubMed  CAS  Google Scholar 

Suzuki S, Hinokio Y, Ohtomo M, Hirai M, Hirai A, Chiba M, Kasuga S, Satoh Y, Akai H, Toyota T (1998) The effects of coenzyme Q10 treatment on maternally inherited diabetes mellitus and deafness, and mitochondrial DNA 3243 (A to G) mutation. Diabetologia 41(5):584–588. https://doi.org/10.1007/s001250050950

Article  PubMed  CAS  Google Scholar 

Bhagavan H, Chopra RKC (2006) Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics. Free Radic Res 40:445–453. https://doi.org/10.1080/10715760600617843

Article  PubMed  CAS  Google Scholar 

Schwartz GJ, Muñoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20(3):629–637. https://doi.org/10.1681/asn.2008030287

Article  PubMed  PubMed Central  Google Scholar 

Schroeder KM, Rizzieri T, Lion RR, Mtenga N, Gisiri M, McFatrich M, Reeve BB (2023) Swahili translation and cultural adaptation of the pediatric patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). J Patient Rep Outcomes 7(1):56. https://doi.org/10.1186/s41687-023-00598-4

Article  PubMed  PubMed Central  Google Scholar 

Gholnari T, Aghadavod E, Hamidi G, Sharifi N, Asemi Z (2017) The effects of coenzyme q10 supplementation on glucose metabolism, lipid profiles, inflammation, and oxidative stress in patients with diabetic nephropathy: a randomized, double-blind, placebo-controlled trial. J Am Coll Nutr 37:1–6. https://doi.org/10.1080/07315724.2017.1386140

Article  CAS  Google Scholar 

Elshamaa MF, Sabry S, Nabih M, Elghoroury EA, El-Saaid GS, Ismail AA (2009) Oxidative stress markers and c-reactive protein in pediatric patients on hemodialysis. Ann Nutr Metab 55(4):309–316. https://doi.org/10.1159/000245938

Article